Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries

Companion animals have been described as potential reservoirs of antimicrobial resistance (AMR), however data remain scarce. Therefore, the objectives were to describe antimicrobial usage (AMU) in dogs and cats in three European countries (Belgium, Italy, and The Netherlands) and to investigate phen...

Full description

Bibliographic Details
Main Authors: Philip Joosten, Daniela Ceccarelli, Evelien Odent, Steven Sarrazin, Haitske Graveland, Liese Van Gompel, Antonio Battisti, Andrea Caprioli, Alessia Franco, Jaap A. Wagenaar, Dik Mevius, Jeroen Dewulf
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/9/2/87
id doaj-b5f7a628115f4962a11c788a8413bd52
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Philip Joosten
Daniela Ceccarelli
Evelien Odent
Steven Sarrazin
Haitske Graveland
Liese Van Gompel
Antonio Battisti
Andrea Caprioli
Alessia Franco
Jaap A. Wagenaar
Dik Mevius
Jeroen Dewulf
spellingShingle Philip Joosten
Daniela Ceccarelli
Evelien Odent
Steven Sarrazin
Haitske Graveland
Liese Van Gompel
Antonio Battisti
Andrea Caprioli
Alessia Franco
Jaap A. Wagenaar
Dik Mevius
Jeroen Dewulf
Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries
Antibiotics
antimicrobial use
antimicrobial resistance
companion animals
critically important antimicrobials
colistin resistance
one health
author_facet Philip Joosten
Daniela Ceccarelli
Evelien Odent
Steven Sarrazin
Haitske Graveland
Liese Van Gompel
Antonio Battisti
Andrea Caprioli
Alessia Franco
Jaap A. Wagenaar
Dik Mevius
Jeroen Dewulf
author_sort Philip Joosten
title Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries
title_short Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries
title_full Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries
title_fullStr Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries
title_full_unstemmed Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries
title_sort antimicrobial usage and resistance in companion animals: a cross-sectional study in three european countries
publisher MDPI AG
series Antibiotics
issn 2079-6382
publishDate 2020-02-01
description Companion animals have been described as potential reservoirs of antimicrobial resistance (AMR), however data remain scarce. Therefore, the objectives were to describe antimicrobial usage (AMU) in dogs and cats in three European countries (Belgium, Italy, and The Netherlands) and to investigate phenotypic AMR. A questionnaire and one fecal sample per animal (<i>n</i> = 303) were collected over one year and AMU was quantified using treatment incidence (TI). Phenotypic resistance profiles of 282 <i>Escherichia coli</i> isolates were determined. Nineteen percent of the animals received at least one antimicrobial treatment six months preceding sampling. On average, cats and dogs were treated with a standard daily dose of antimicrobials for 1.8 and 3.3 days over one year, respectively. The most frequently used antimicrobial was amoxicillin-clavulanate (27%). Broad-spectrum antimicrobials and critically important antimicrobials for human medicine represented 83% and 71% of the total number of treatments, respectively. Resistance of <i>E. coli</i> to at least one antimicrobial agent was found in 27% of the isolates. The most common resistance was to ampicillin (18%). Thirteen percent was identified as multidrug resistant isolates. No association between AMU and AMR was found in the investigated samples. The issue to address, regarding AMU in companion animal, lies within the quality of use, not the quantity. Especially from a One-Health perspective, companion animals might be a source of transmission of resistance genes and/or resistant bacteria to humans.
topic antimicrobial use
antimicrobial resistance
companion animals
critically important antimicrobials
colistin resistance
one health
url https://www.mdpi.com/2079-6382/9/2/87
work_keys_str_mv AT philipjoosten antimicrobialusageandresistanceincompanionanimalsacrosssectionalstudyinthreeeuropeancountries
AT danielaceccarelli antimicrobialusageandresistanceincompanionanimalsacrosssectionalstudyinthreeeuropeancountries
AT evelienodent antimicrobialusageandresistanceincompanionanimalsacrosssectionalstudyinthreeeuropeancountries
AT stevensarrazin antimicrobialusageandresistanceincompanionanimalsacrosssectionalstudyinthreeeuropeancountries
AT haitskegraveland antimicrobialusageandresistanceincompanionanimalsacrosssectionalstudyinthreeeuropeancountries
AT liesevangompel antimicrobialusageandresistanceincompanionanimalsacrosssectionalstudyinthreeeuropeancountries
AT antoniobattisti antimicrobialusageandresistanceincompanionanimalsacrosssectionalstudyinthreeeuropeancountries
AT andreacaprioli antimicrobialusageandresistanceincompanionanimalsacrosssectionalstudyinthreeeuropeancountries
AT alessiafranco antimicrobialusageandresistanceincompanionanimalsacrosssectionalstudyinthreeeuropeancountries
AT jaapawagenaar antimicrobialusageandresistanceincompanionanimalsacrosssectionalstudyinthreeeuropeancountries
AT dikmevius antimicrobialusageandresistanceincompanionanimalsacrosssectionalstudyinthreeeuropeancountries
AT jeroendewulf antimicrobialusageandresistanceincompanionanimalsacrosssectionalstudyinthreeeuropeancountries
_version_ 1724885769760276480
spelling doaj-b5f7a628115f4962a11c788a8413bd522020-11-25T02:17:32ZengMDPI AGAntibiotics2079-63822020-02-01928710.3390/antibiotics9020087antibiotics9020087Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European CountriesPhilip Joosten0Daniela Ceccarelli1Evelien Odent2Steven Sarrazin3Haitske Graveland4Liese Van Gompel5Antonio Battisti6Andrea Caprioli7Alessia Franco8Jaap A. Wagenaar9Dik Mevius10Jeroen Dewulf11Veterinary Epidemiology Unit, Department of Obstetrics, Reproduction and Herd Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, BelgiumDepartment of Bacteriology and Epidemiology, Wageningen Bioveterinary Research, Houtribweg 39, 8221 RA Lelystad, The NetherlandsVeterinary Epidemiology Unit, Department of Obstetrics, Reproduction and Herd Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, BelgiumVeterinary Epidemiology Unit, Department of Obstetrics, Reproduction and Herd Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, BelgiumDepartment of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584 CL Utrecht, The NetherlandsInstitute for Risk Assessment Sciences, Utrecht University, Yalelaan 2, 3584 CM Utrecht, The NetherlandsIstituto Zooprofilattico Sperimentale del Lazio e della Toscana “M. Aleandri”, Department of General Diagnostics, National Reference Laboratory for Antimicrobial Resistance, Via Appia Nuova, 1411, 00178 Rome, ItalyIstituto Zooprofilattico Sperimentale del Lazio e della Toscana “M. Aleandri”, Department of General Diagnostics, National Reference Laboratory for Antimicrobial Resistance, Via Appia Nuova, 1411, 00178 Rome, ItalyIstituto Zooprofilattico Sperimentale del Lazio e della Toscana “M. Aleandri”, Department of General Diagnostics, National Reference Laboratory for Antimicrobial Resistance, Via Appia Nuova, 1411, 00178 Rome, ItalyDepartment of Bacteriology and Epidemiology, Wageningen Bioveterinary Research, Houtribweg 39, 8221 RA Lelystad, The NetherlandsDepartment of Bacteriology and Epidemiology, Wageningen Bioveterinary Research, Houtribweg 39, 8221 RA Lelystad, The NetherlandsVeterinary Epidemiology Unit, Department of Obstetrics, Reproduction and Herd Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, BelgiumCompanion animals have been described as potential reservoirs of antimicrobial resistance (AMR), however data remain scarce. Therefore, the objectives were to describe antimicrobial usage (AMU) in dogs and cats in three European countries (Belgium, Italy, and The Netherlands) and to investigate phenotypic AMR. A questionnaire and one fecal sample per animal (<i>n</i> = 303) were collected over one year and AMU was quantified using treatment incidence (TI). Phenotypic resistance profiles of 282 <i>Escherichia coli</i> isolates were determined. Nineteen percent of the animals received at least one antimicrobial treatment six months preceding sampling. On average, cats and dogs were treated with a standard daily dose of antimicrobials for 1.8 and 3.3 days over one year, respectively. The most frequently used antimicrobial was amoxicillin-clavulanate (27%). Broad-spectrum antimicrobials and critically important antimicrobials for human medicine represented 83% and 71% of the total number of treatments, respectively. Resistance of <i>E. coli</i> to at least one antimicrobial agent was found in 27% of the isolates. The most common resistance was to ampicillin (18%). Thirteen percent was identified as multidrug resistant isolates. No association between AMU and AMR was found in the investigated samples. The issue to address, regarding AMU in companion animal, lies within the quality of use, not the quantity. Especially from a One-Health perspective, companion animals might be a source of transmission of resistance genes and/or resistant bacteria to humans.https://www.mdpi.com/2079-6382/9/2/87antimicrobial useantimicrobial resistancecompanion animalscritically important antimicrobialscolistin resistanceone health